Shifeng Mao
AHN Cancer Institute-Med Onc & Infusions at Allegheny General Hospital
Office
(412) 325-5700
Fax (412) 442-2570 314 East North Avenue, Pittsburgh, PA 15212Call today!
About
Shifeng Mao
Shifeng S Mao, MD, PhD, is the chair of the AHN Cancer Institute urological oncology team. His practice and research focus on genitourinary cancers, including prostate cancer, bladder cancer, kidney cancer, and testicular cancer. He is an Associate Professor Medicine at Drexel University College of Medicine. Dr. Mao is an active researcher and the principal investigator of many clinical trials. He has active collaborations with colleagues from Johns Hopkins Kimmel Cancer Center and Carnegie Mellon University. He is the recipient of American Society of Clinical Oncology (ASCO) Young Investigator Award. He has published many research studies in medical journals and presented his findings at national conferences. His experience in cancer research gives him a unique perspective and insight into the biology of cancer, which enhances his clinical care with patients. Dr. Mao earned his medical degree from Beijing Medical University and his doctorate in medical pathology from University of Tennessee Health Science Center. He completed his residency at New York University School of Medicine and continued his studies through a fellowship at the University of Texas Medical School at Houston/MD Anderson Cancer Center.
Primary Specialty
Hematologist
Practice
AHN Cancer Institute-Med Onc & Infusions at Allegheny General Hospital
Gender
Male
Education
Beijing Medical University
Training
New York University School of Medicine Internship Residencies, University of Texas MD Anderson Cancer Center
Certification
American Board of Internal Medicine-Hematology, American Board of Internal Medicine-Medical Oncology
Accepting New Patients
Degrees
Medical Doctor
Admitting Hospitals
Allegheny General Hospital, Allegheny Valley Hospital, West Penn Hospital, Jefferson Hospital, Forbes Hospital
Office Name
AHN Cancer Institute-Med Onc & Infusions at Allegheny General Hospital
Languages
Chinese - Mandarin, English
Business Hours
Monday:10:00 AM - 4:00 PM
Tuesday:10:00 AM - 4:00 PM
Wednesday:10:00 AM - 4:00 PM
Thursday:10:00 AM - 4:00 PM
Friday:10:00 AM - 4:00 PM
Saturday:Closed
Sunday:Closed
Services
urethral cancer, transitional cell carcinoma, testicular cancer, prostate cancer clinical trials, penile cancer chemotherapy, penile cancer, non-clear cell kidney cancer, malignant neoplasm of ureter, kidney cancer clinical trials, human papillomavirus (hpv) related penile cancer, cancer clinical trials, bladder cancer immunotherapy, bladder cancer clinical trials, active surveillance for kidney cancer, clear cell renal cancer, chemotherapy iv infusion, multi-cancer early detection blood test, testicular tumor, adjuvant chemotherapy, advanced malignancies, systemic therapy, intravesical chemotherapy, hereditary kidney cancer, personal history of chemotherapy, hyperthermic intraperitoneal chemotherapy (hipec), prostate cancer chemotherapy, bladder cancer chemotherapy, testicular cancer chemotherapy, hormone based chemotherapy, intravesical therapy, carcinoma of unknown primary, targeted molecular therapy, intrathecal chemotherapy, maintenance chemotherapy, consolidation chemotherapy, induction chemotherapy, urachal tumor, clinical trials, intraarterial chemotherapy of tumors, genitourinary cancers, cancer immunotherapy, prostate cancer, abdominal chemotherapy, abdominal cancer, bladder cancer, scrotal tumor, kidney cancer, intraperitoneal hyperthermic chemoperfusion, cancer pain, cancer genomics, cancer during pregnancy, biological targeted therapy, cancer chemotherapy, cancer
Additional Services
Oncologist
Consumer Feedback
Add a Review
There are no recent reviews. Be the first!